<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
XLO
Xilio Therapeutics
$
()


  • Xilio Therapeutics announces initial data from Phase 1C trial for XTX101

    11/7/2024 - 09:19am
  • Xilio Therapeutics expects cash to fund operations into Q2 of 2025

    11/7/2024 - 09:10am
  • Xilio Therapeutics reports Q3 EPS (22c), consensus (25c)

    11/7/2024 - 09:10am
  • Xilio Therapeutics reports Q2 EPS (24c) vs (70c) last year

    8/8/2024 - 07:50am
  • Xilio Therapeutics expects cash to fund operations into Q2 of 2025

    5/14/2024 - 07:37am
  • Xilio Therapeutics reports Q1 EPS (62c) vs (83c) last year

    5/14/2024 - 07:36am
  • Xilio Therapeutics files to sell 17.58M shares of common stock for holders

    4/30/2024 - 17:11pm
  • Fly Insider: Xilio, Aerovate among week’s notable insider trades

    4/8/2024 - 15:18pm
  • Xilio Therapeutics reports Q4 EPS (64c), consensus (64c)

    4/1/2024 - 16:14pm
  • Gilead sees FY24 EPS reduction of 3c-4c from Xilio Therapeutics deal

    3/28/2024 - 07:22am
  • Xilio Therapeutics, Gilead announce exclusive license agreement for XTX301

    3/28/2024 - 07:13am
  • Xilio Therapeutics announces $11.3M private placement equity financing

    3/28/2024 - 07:10am
  • Xilio to get $43.5M upfront in pact with Gilead to develop/commercialize XTX301

    3/28/2024 - 07:10am
  • Xilio Therapeutics sees advances across clinical pipeline, announces XTX30 data

    1/8/2024 - 08:01am
dynamic_feed Breaking News